Vaccine News and Research

Latest Vaccine News and Research

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza and last longer than vaccines currently in use.

31 Oct 2023

AI may help identify potential gonorrhea vaccine proteins

Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics.

31 Oct 2023

Scientists identify mechanism causing deadly blood clots after some COVID-19 vaccines

A mechanism that led some patients to experience cases of deadly clotting following some types of Covid-19 vaccination has been identified in new research.

30 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

Government updates regulations to support the ongoing delivery of Covid and flu vaccinations

The government has taken action to ensure Covid-19 and influenza vaccinations continue to be delivered safely and swiftly following widespread support in a public consultation.

30 Oct 2023

Study provides deeper insight into safety of COVID-19 vaccines for couples planning pregnancy

Multiple studies have shown that the COVID-19 vaccines do not lead to infertility or pregnancy complications such as miscarriage, but many people are still wary of adverse effects from the vaccine on pregnancy.

30 Oct 2023

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5.

30 Oct 2023

New bivalent vaccine shows promising results against key fish pathogens

The efficacy of a bivalent vaccine against Aeromonas hydrophila (A. hydrophila) and Streptococcus agalactiae (S. agalactiae).

30 Oct 2023

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

Redefining the battle against Alzheimer's with tau-focused treatments

Researchers explore the potential of tau-targeting therapies in treating Alzheimer's disease, focusing on immunotherapies and strategies to improve their efficacy. The study dives into the complex biology of tau proteins, their modifications, and how they can be targeted to halt the progression of Alzheimer's.

29 Oct 2023

Broad spread and upsurge cholera outbreak in Africa

Announcing a new article publication for Zoonoses journal. A multi-country cholera outbreak has occurred in several developing countries in Africa, Asia and Oceania since mid-2021.

27 Oct 2023

A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.

27 Oct 2023

Malaria protein discovery opens new avenues for combating deadly infection

The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite's immune evasion tactics could pave the way for new vaccines or therapeutics to combat the deadly infection.

26 Oct 2023

Study helps identify children at the highest risk of severe RSV infection

A new study helps to identify children who are at the highest risk of a severe respiratory syncytial virus (RSV) infection and who would thus benefit most from new RSV prevention measures.

26 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Zika virus infection in pregnant rhesus macaques slows fetal growth and affects how infants and mothers interact in the first month of life, according to a new study from researchers at the California National Primate Research Center at the University of California, Davis.

25 Oct 2023

Oxford Vaccine Group launches a pioneering study into human immunity

Previous
1
...
49
50
51
52
53
54
55
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

AI may help identify potential gonorrhea vaccine proteins

Scientists identify mechanism causing deadly blood clots after some COVID-19 vaccines

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

Government updates regulations to support the ongoing delivery of Covid and flu vaccinations

Study provides deeper insight into safety of COVID-19 vaccines for couples planning pregnancy

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

New bivalent vaccine shows promising results against key fish pathogens

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Redefining the battle against Alzheimer's with tau-focused treatments

Broad spread and upsurge cholera outbreak in Africa

A new era of vaccines leaves old questions about prices unanswered

Malaria protein discovery opens new avenues for combating deadly infection

Study helps identify children at the highest risk of severe RSV infection

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

Zika virus exposure during pregnancy slows fetal growth and affects mother-infant interaction

Oxford Vaccine Group launches a pioneering study into human immunity

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Epidemic: What good is a vaccine when there is no rice?

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in